World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
40317
World Ranking
7629
National Ranking
3974

Overview

Thomas B. Cooper is affiliated with Columbia University in the United States and has contributed to research primarily within the fields of Neuroscience and Medicine.

Their work spans several subfields, including Biological Psychiatry, Behavioral Neuroscience, Pharmacology, Neurology, and Archeology. The research topics covered include:

  • Tryptophan and brain disorders
  • Stress Responses and Cortisol
  • Treatment of Major Depression
  • Advanced MRI Techniques and Applications
  • Fatty Acid Research and Health
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Neurosurgical Procedures and Complications

Cooper has published research articles in various reputable venues. Frequent publication venues include:

  • Neuropsychopharmacology
  • JAMA Network Open
  • Journal of Psychiatric Research
  • International Journal of Obstetric Anesthesia
  • Biological Psychiatry

Among their recent papers are:

  • "Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine" (2020, Neuropsychopharmacology)
  • "Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression" (2020, JAMA Network Open)
  • "Relationships between inflammatory markers and suicide risk status in major depression" (2020, Journal of Psychiatric Research)
  • "Intracranial arachnoid cyst in pregnancy: case report, literature review and evaluation of neuraxial anaesthesia risk" (2023, International Journal of Obstetric Anesthesia)
  • "Relationships Between Inflammatory Markers and Suicide Risk Status in Major Depression" (2020, Biological Psychiatry)

Cooper collaborates regularly with a group of frequent co-authors, including:

  • Raymond F. Suckow
  • Licínia Ganança
  • Hanga Galfalvy
  • Zahra Basseda
  • Maria Luísa Figueira

Best Publications

  • Serotonergic Studies in Patients with Affective and Personality Disorders: Correlates with Suicidal and Impulsive Aggressive Behavior

    Emil F. Coccaro;Larry J. Siever;Howard M. Klar;Gail Maurer

  • Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

    Anissa Abi-Dargham;Janine Rodenhiser;David Printz;Yolanda Zea-Ponce

  • The psychotomimetic effects of intravenous Delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis

    Deepak Cyril D'Souza;Edward Perry;Lisa MacDougall;Yola Ammerman

  • Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

    Harold A. Sackeim;Roger F. Haskett;Benoit H. Mulsant;Michael E. Thase

  • Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

    Deepak Cyril D’Souza;Walid Michel Abi-Saab;Walid Michel Abi-Saab;Steven Madonick;Kimberlee Forselius-Bielen

  • Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

    Robert M. Bilder;Robert S. Goldman;Jan Volavka;Pal Czobor

  • Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics

    Jean Pierre Lindenmayer;Pal Czobor;Jan Volavka;Leslie Citrome

  • Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial.

    Alexander H. Glassman;Fay Stetner;B. Timothy Walsh;Pamela S. Raizman

  • Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

    Barbara Geller;Thomas B. Cooper;Kai Sun;Betsy Zimerman

  • Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.

    Diana Martinez;Mark Slifstein;Allegra Broft;Osama Mawlawi

  • Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD.

    Laurence Greenhill;Scott Kollins;Howard Abikoff;James Mccracken

  • Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.

    Lawrence S. Kegeles;Anissa Abi-Dargham;W. Gordon Frankle;Roberto Gil

  • Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

    Jan Volavka;Pal Czobor;Brian Sheitman;Jean Pierre Lindenmayer

  • Imaging endogenous dopamine competition with [11C]raclopride in the human brain

    M.D. Nora D. Volkow;M.D. Nora D. Volkow;Gene-Jack Wang;Joanna S. Fowler;Jean Logan

  • Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

    Lawrence S Kegeles;Anissa Abi-Dargham;Yolanda Zea-Ponce;Janine Rodenhiser-Hill

  • Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography

    D. P. Uzunov;T. B. Cooper;E. Costa;Alessandro Guidotti

  • Circadian time of morning light administration and therapeutic response in winter depression.

    Jiuan Su Terman;Michael Terman;Ee-Sing Lo;Thomas B. Cooper

  • Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia

    Robert M. Bilder;Jan Volavka;Pál Czobor;Anil K. Malhotra

  • Cerebrospinal Fluid Vasopressin Levels: Correlates With Aggression and Serotonin Function in Personality-Disordered Subjects

    Emil F. Coccaro;Richard J. Kavoussi;Richard L. Hauger;Thomas B. Cooper

  • Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients

    Sally Szymanski;Jeffrey A. Lieberman;Jose M. Alvir;David Mayerhoff

Frequent Co-Authors

Jan Volavka
Jan Volavka New York University
Maria A. Oquendo
Maria A. Oquendo University of Pennsylvania
Jeffrey A. Lieberman
Jeffrey A. Lieberman Columbia University
Leslie Citrome
Leslie Citrome New York Medical College
Joseph P. McEvoy
Joseph P. McEvoy Augusta University
Harold A. Sackeim
Harold A. Sackeim Columbia University
Lawrence S. Kegeles
Lawrence S. Kegeles Columbia University
Hanga Galfalvy
Hanga Galfalvy Columbia University
Leo Sher
Leo Sher Icahn School of Medicine at Mount Sinai
Larry J. Siever
Larry J. Siever Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can offer flexibility and new career options in healthcare beyond traditional medicine. Many students pursue specialized programs such as accelerated lpn pathways, which allow individuals to become Licensed Practical Nurses more quickly—ideal for those wanting to join the workforce sooner.

For advanced roles, mental health is a growing field. online msn pmhnp programs prepare registered nurses for psychiatric mental health nurse practitioner positions, opening doors in clinical, hospital, or private practice settings.

Interested in the business side of healthcare? Consider an online master of health administration to gain skills in leadership, hospital management, and operations. Those seeking additional value can find the cheapest mha programs online healthcare, making this advanced degree more accessible and affordable than ever before.

Whether you aim for hands-on patient care or healthcare leadership, online degrees offer flexible, accredited, and cost-effective routes to success in the medical field.

Best Scientists Citing Thomas B. Cooper

Trending Scientists

Recently Published Articles